investment environment throughout the country. Cost of goods sold and services decreased in portion of decreasing revenue but expenses were At the same level as last year. The Company had net profit for the
impairment loss from the liquidation of Solvay Biochemicals (Taixing) Limited (“SBT”) were fully booked in 2017. * Note Please find further information in the consolidated financial statements. 2 Summary of
, the impact of lease income were excluded from the analysis of the operation result. Profit from operation of EGCO Group before the effects of foreign exchange, deferred income tax, impairment and lease
million or 22.02% from the same period of last year, the main factors that contributed to the increase in revenue were the number of visits and the attendance of both inpatients and outpatients and revenue
of the previous year which were 3.68:1 and 0.19:1 times, respectively, indicating that the Company still stable financial status and capable to pay trade liabilities. Please be informed accordingly
“Company”) submitted its separate financial statement and its consolidated financial statement for the second quarter of 2018 and 6 months ended on 30 June 2018 which were reviewed by the auditor. The
Assets Total assets as at June 30, 2018 was Baht 9,745 million, decreased by Baht 38 million or 0.4% from the year end of 2017, which is explained as follows, Current assets were Baht 3,763 million
million due to the slowdown of investment environment throughout the country. Cost of goods sold and services decreased in portion of decreasing revenue but expenses were At the same level as last year. The
transaction to complete the disposal of the subsidiaries’ assets of not exceeding to 1,200 million Baht for the Company. The total value of the 2 agreements were 14,000 million Baht. The summary of significant